NCT03078127 Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis Status COMPLETED Phase NA
NCT03068312 A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation Status COMPLETED Phase PHASE3
NCT03066453 Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis Status TERMINATED Phase PHASE3
NCT03061331 Lumacaftor/Ivacaftor Combination Therapy in Subjects With CF Who Have an A455E CFTR Mutation Status COMPLETED Phase PHASE2
NCT03058068 Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis Status WITHDRAWN Phase PHASE1
NCT03056989 A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT03056326 A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03052556 Human Papillomavirus and Cervical Dysplasia in Women With Cystic Fibrosis Status COMPLETED Phase NA
NCT03052283 Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score) Status RECRUITING Phase N/A
NCT03052231 Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center Status COMPLETED Phase NA
NCT03051490 RESULT: Reliable, Emergent Solution Using Liprotamase Treatment Status UNKNOWN Phase PHASE3
NCT03045523 A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT03041571 Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students Status WITHDRAWN Phase N/A
NCT03029455 A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT03020719 The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2